Vernon, John

Vernon, John M. 1981. Concentration, Promotion, and Market Share Stability in the Pharmaceutical Industry. Journal of Industrial Economics 19(3) 246-266. 

Vernon, John M., and Peter Gusen. 1974. Technical Change and Firm Size Pharmaceutical Industry. Review of Economics and Statistics 56 294—302. 

For discussions concerning informed consent and medical experimentation on prison populations, see Mark, Vernon H, Neville, Robert, (1977) Brain Surgery in Aggressive Epileptics Social and Ethical Implications. Ethical Issues in Modern Medicine, (eds, Robert Hunt John Arras). Veatch, Robert M, (1977). Case Studies In Medical Ethics, pp, 267-71 Bernier, Barbara L, (1994) Class, Race, And Poverty Medical Technologies And Socio-Political Choices. 11 Harv. BlackLetter J. 115,... 

Henry Grabowski John M. Vernon, Brand Loyalty, Entry and Price Competition In Pharmaceuticals After the 1984 Drug Act, 35 J. of Lnw Boon. 331-50 (Oct. 1992). 

Giaccotto, Carmelo, Rexford E. Santerre, and John A. Vernon. 2005. Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry. Journal of Law and Economics 48(1) 195-214. 

Grabowski, Henry, and John M. Vernon. 1990. A New Look at the Return and Risks to Pharmaceutical R D. Management Science 36 804-821. 

Grabowski, Henry, and John Vernon. 1992. Brand LoyaltyEntry and Price Competition in Pharmaceuticals after the 1984 Act. Journal of Law and Economics 35(2) 331-350. 

Grabowski, Henry, and John Vernon. 1996. Longer Patents for Increased Generic Competition The Waxman-Hatch Act after One Decade. PharmacoEconomics 10 (Suppl. 2) 110-123. 

Grabowski, Henry, and John Vernon. 2000. Effective Patent Life in Pharmaceuticals. International Journal of Technology Management 19(l-2) 98-120. 

Grabowski, Henry, John M. Vernon, and Lacy Glenn Thomas. 1978. Estimating the Effects of Regulation on Innovation An International Comparative Analysis of the Pharmaceutical Industry. Journal ofEaw and Economics 21(1) 133-163. 

Dean AJ, Moses GM, Vernon JM. Suspected withdrawal syndrome after cessation of St. John s wort. Ann Pharmacother 2003 37(1) 150. 

Santerre, Rexford E., John A. Vernon, and Carmelo Giacotto. The Impact of Indirect Government Controls on U.S. Drug Prices and R D. Cato... 

W. V. Harcourt, Address by the Rev. W. Vernon Harcourt , Report of the Ninth Meeting of the British Associationfor the Advancement of Science held at Birmingham in August 1839 (London John Murray, 1840), pp. 3-69. 

I appreciate the donation by C. Blake of a fine linen napkin for experimental purposes. Helpful conversations were held with Eric Jumper, Alan Adler, John Heller, K. Rengan, Mel Usselman, Carroll Osborn, and Vernon Miller. 

Ashforth, John Tehranian, Michael Kwass, Jesse Ribot, Ezra Suleiman, Jim Boyce, Jeff Burds, Fred Cooper, Ann Stoler, Atul Kohli, Orlando Figes, Anna Tsing, Vernon Ruttan, Henry Bernstein, Michael Watts, Allan Fred, Witoon Permpongsacharoen, Gene Ammarell, and David Feeny. 

Henry Grabowski and John Vernon, Innovation and Structural Change in Pharmaceuticals and Biotechnology, Industrial and Corporate Change 3 (1994) 435-448. 

John M. Vernon, Department of Chemistry, University of York, Heslington, York YOl 5DD, England (183)... 

---